Portfolio company
Brainbox Solutions
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops AI-enabled diagnostic tests and biomarker panels to aid clinicians in diagnosing and predicting recovery for patients with mild traumatic brain injuries.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Banyan Biomarkers
This company develops blood tests to detect mild traumatic brain injuries for healthcare providers and clinical diagnostic laboratories.
BrainQ
This company develops non-invasive, AI-guided electromagnetic neurorehabilitation devices and cloud-based monitoring platforms for stroke survivors and patients with neurological disorders to support recovery.
GLX Analytix
This company develops blood-based diagnostic and monitoring tests for clinicians to manage neurodegenerative, autoimmune and neuropsychiatric diseases using glycocalyx biomarkers and artificial intelligence.
BrainQuant
This company develops artificial intelligence software that analyses magnetic resonance imaging sequences to detect neurodegenerative diseases for medical institutions and clinical researchers.
BrainDTech
The company develops a diagnostic platform using microRNA biomarkers from liquid biopsies for the early detection and monitoring of neurodegenerative diseases for healthcare providers.
CranioSense
This company develops non-invasive diagnostic systems to monitor intracranial pressure for emergency care teams and clinicians treating traumatic brain injuries.
neuroClues
This company develops portable eye-tracking medical devices and AI software for clinicians to identify neurological disorders through ocular biomarkers.
Hemispheric
This company develops artificial intelligence models and platforms for decoding non-invasive brain signals to assist clinicians and researchers with neurological and psychiatric diagnoses.
